Nivolumab and ipilimumab combination treatment in patients with advanced uterine leiomyosarcoma: Results from the phase II MoST-CIRCUIT trial (ESMO Asia 2026) - Oct 1, 2026 - Abstract #475RO; Pres time: Dec 6, 2026; 09:37 AM - 09:42 AM; Location: Hall 405; No abstract available
Clinical • Metastases • P2 data • Leiomyosarcoma • Oncology • Sarcoma • Solid Tumor • Uterine Leiomyosarcoma
|